GlassScriptPhysician profile
Ezra A Berkowitz
NPI 1104009067
$3,208.43
in general payments reported to CMS, 2019-2025
10 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,295 · 2021: $14.42 · 2022: $455 · 2023: $616 · 2024: $161 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200 · Travel and Lodging: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.93 |
| Travel and Lodging | $244.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $1,740.85 | 2020-2025 | |
| Stryker Corporation | $387.93 | 2023-2025 | Ortholoc 3di, Inbone, Infinity Adaptis |
| Arthrex, INC. | $298.20 | 2025 | |
| Zimmer Biomet Holdings, INC. | $294.48 | 2022-2023 | Tapestry |
| Smith+Nephew, INC. | $215.99 | 2022-2023 | Evos |
| Lifenet Health | $121.21 | 2024 | Quadlink, Graftlink |
| Vericel Corporation | $50.00 | 2025 | Maci |
| Pacira Pharmaceuticals Incorporated | $46.14 | 2021-2024 | Exparel |
| Heron Therapeutics, INC. | $31.85 | 2025 | Zynrelef |
| Pfizer INC. | $21.78 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ezra Berkowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.